INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Rapid, Seamless Upstream Process Development And Scale-Up For CHO-K1 Cells
Accelerate your biotech company's scale-up process while delivering consistent and strong cell growth, productivity, and product quality.
-
EU GMP-Annex 1: Changes, Challenges, And Ready-To-Use Sterile Packaging
Leveraging a pre-sterilized containment solution that meets the requirements of Annex 1 and outsources non-core activities can help prevent contamination and reduce the effort and liability of the CCS.
-
Extractables And Leachables Testing
Learn how to navigate the extractables and leachables regulatory landscape and implement best practices for leachables analysis in your pharmaceutical development process.
-
Water For Injection: Strategic Utility And The Case For Outsourcing
Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.
-
Rethinking Liquid Handling Automation10/1/2025
Labs today require more than precision—they need systems built for flexibility, reproducibility, and trust. Explore how automation is evolving to meet the real-world needs of modern scientific teams
-
Thermo Fisher Scientific Large Volume Liquid Expansion5/2/2024
Take an insightful look into the expansion of the large volume liquids manufacturing site at the Grand Island facility, highlighting the various stages of the manufacturing process and the capabilities it offers to support the bioprocessing industry.
-
Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications6/19/2025
Discover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.
-
Delivering On GLP-1 Demand: Combining Device And Supply Strategy5/7/2024
Meeting the demand for GLP-1 treatments requires robust and efficient delivery systems. Review how innovative solutions offer customization, streamlined manufacturing, and formulation compatibility.
-
Solve ATMP Aseptic Filling Challenges With Gloveless Isolators1/9/2026
Human intervention is the top contamination risk in ATMP manufacturing. Robotic gloveless isolators address that risk through full automation and real-time monitoring during aseptic filling.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Levitating transport technology is redefining aseptic production. Reduce your footprint and carbon impact while streamlining the fill-finish process with a simplified, frictionless workflow.
-
ASEPTiCell is integrated with isolator-barrier technologies to fully enclose and tightly control the aseptic environment for ideal conditions for processing sterile drug products. The system can be configured with a Restricted Access Barrier System (RABS) or an aseptic isolator to provide uninterrupted aseptic conditions during production. With isolator integrated systems, the ASEPTiCell is completely compatible with repeated in-situ bio-decontamination using hydrogen peroxide to further enhance the sterility assurance of the system.
-
Dec’s ability to provide end-to-end solutions from API manufacturing to primary packaging filling covers the complete range from R&D processes and small batches to large filling campaigns. Our solutions include state of the art robotics for the filling and handling of complex delivery systems like pre-filled syringes (PFS).
-
LAF systems provide product protection across various work area sizes, including sampling, process technology, and sterile filling for pharmaceutical and related applications.
-
cryoFIL® enhances cell viability and maximizes yield through automated cryovial filling and handling.